跳至主要内容
临床试验/CTRI/2024/11/076493
CTRI/2024/11/076493招募中2 期

A Comparative Pharmaceutico-Analytical Study Between Two Formulations of Rohitakasava and Its Clinical Evaluation W.S.R to Pandu Roga

Dr Bhoomika V1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年11月16日最近更新:

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
30
试验地点
1
主要终点
Patient improved health condition

研究概览

简要总结

A randomized parallel study was conducted with 30 patients, ensuring a balanced comparison between treatment groups to evaluate the effectiveness of the interventions of Pandu Roga. Pandu Rogais a disease in which there is altered skin color(Panduta). About 8.8% of global population is affected in all age groups.

There are many Shamanaushadhis mentioned in classical text of Ayurveda indicated inPandu RogaAushadha to be selected inPandu Roga should posses properties likeDeepana, Pachana, Kapha-Pittashamaka, Vatanulomaka, Rakta prasadaka, Rakta shodhaka, Rasayana.

Rohitakasava is one such formulation mentioned inGadanigraha Asavadhikara indicated in Pandu Roga and more.

There are two references of Rohitakasava, one formulation with ingredients of Rohitaka, Triphala, Dhataki pushpa, Panchakola, Guda and other formulation contains Rohitaka, Dhataki pushpa, Trijata, Panchakola, Guda.

As both are indicated in Pandu Roga with slight changes in drugs and their ratio, the formulation which is efficacious and of standard quality has to be evaluated.

研究设计

研究类型
Interventional
分配方式
Coin toss, Lottery, toss of dice, shuffling cards etc
盲法
None

入排标准

年龄范围
15.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Hb level above 7gm/dL and below 11gm/dL 2) Patients with lakshanas of Pandu Roga as mentioned in classics.

排除标准

  • Hb level below 7gm/dL and above 11gm/dL 2) Pregnancy and Lactation 3) Severe Renal/Hepatic/Cardiac disease 4) Any continuing blood loss diseases 5) Patients with Type 1 and Type 2 Diabetes Mellitus.

结局指标

主要结局

Patient improved health condition

时间窗: 28th day

Increased hemoglobin level

时间窗: 28th day

Decreased classical lakshanas of Pandu roga

时间窗: 28th day

次要结局

  • Patient improved health condition before the completion of treatment(21st day)

研究者

发起方
Dr Bhoomika V
申办方类型
Other [self]
责任方
Principal Investigator
主要研究者

Dr Bhoomika V

KVG Ayurveda Medical College and Hospital

研究点 (1)

Loading locations...

相似试验